The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial

BACKGROUND: At present, intraocular injection of anti-VEGF (vascular endothelial growth factor) drugs has replaced traditional laser therapy as the first-line treatment for DME (diabetic macular edema). However, ranibizumab, a commonly used anti-VEGF drug, is expensive and requires multiple intraocu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mi, Xuejing, Gu, Xiaoya, Yu, Xiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438173/
https://www.ncbi.nlm.nih.gov/pubmed/36056443
http://dx.doi.org/10.1186/s13063-022-06593-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438173/
https://www.ncbi.nlm.nih.gov/pubmed/36056443
http://dx.doi.org/10.1186/s13063-022-06593-2

Ejemplares similares